DialSDelaneyJACBarkunANSuissaS. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA2005;294:2989–95.
2.
DialSDelaneyJACSchneiderVSuissaS. Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy. CMAJ2006;175:745–8.
3.
LoweDOMamdaniMMKoppAProton pump inhibitor and hospitalization for Clostridium difficile-associated disease: a population-based study. Clin Infect Dis2006;43:1272–6.
4.
LaheijRJFSturkenboomMCJMHassingRJRisk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA2004;292:1955–60.
5.
GulmezSEHolmAFrederiksenHJensenTGUse of proton pump inhibitors and the risk of community-acquired pneumonia. Arch Intern Med.2007;167:950–5.
6.
YangYXLewisJDEpsteinSMetzDC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA2006;296:2947–53.
7.
VestergaardPRejnmarkLMosekildeL. Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int2006;79:76–83.
8.
JumpRLPPultzMJDonskeyCJ. Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea. Antimicrob Agents Chemother2007;51:2883–7.
9.
NakamuraMOdaMAkibaYAutoradiographic demonstration of lansoprazole uptake sites in rat antrum and colon. J Clin Gastroenterol1995;20 (suppl 2):S8–S13.
10.
AgastyaGWestBCCallahanJM. Omeprazole inhibits phagocytosis and acidification of phagolysosomes of normal human neutrophils in vitroImmnunopharmacol Immunotoxicol2000;22:357–72.
11.
YoshidaNYoshikawaTTanakaYA new mechanism for anti-inflammatory actions of proton pump inhibitors — inhibitory effects on neutrophil-endothelial cell interactions. Aliment Pharmacol Ther2000;14 (suppl 1):74–81.
12.
ReckerRR. Calcium absorption and achlorhydria. N Engl J Med.1985;313:70–3.
13.
O'ConnellMBMaddenDMMurrayAMEffects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J Med.2005;118:778–81.
14.
ZaidiM. Modularity of osteoclast behaviour and “mode-specific” inhibition of osteoclast function. Biosci Rep1990;10:547–56.
